Awardees
THE SIR WILLIAM OSLER YOUNG INVESTIGATOR AWARD
Awardees in 2023
Suman Paul, M.B.B.S., Ph.D.
Johns Hopkins University School of Medicine
(48th recipient at the 225th ICC meeting,
Baltimore 11-03-23)
“Developing antibodies for the treatment of T cell lymphomas and leukemias”
Elizabeth Bjoj, M.D., Ph.D.
Children’s Hospital of Philadelphia, Perelman School of Medicine
(47th recipient at 224th ICC Meeting, Philadelphia 4-14-23) “Discovering Novel Pediatric Neurodegeneration Syndromes to Better Understand Dementia”
Awardees in 2022
Bridget Marcellino, M.D., Ph.D.
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
(46th recipient at 223rd ICC Meeting, New York 11-4-22) “Targeting PPM1D in Myeloproliferative Neoplasms”
Nora Barrett, M.D.
Brigham and Women’s Hospital and Harvard Medical School
(45th Recipient at 222nd ICC Meeting, Boston, 4-1-22)
“Stem Cell Dysplasia in Chronic Airway Inflammation”
Awardees in 2019
Michael Kornberg, M.D., Ph.D.
Johns Hopkins University School of Medicine
(44th recipient at 220th ICC Meeting, Baltimore 11-1-19) “Targeting metabolism in autoimmune disease: Insights from a multiple sclerosis drug”
Katharine J. Bar, M.D.
Perelman School of Medicine
(43rd recipient at 219th ICC Meeting, Philadelphia 4-12-19) “Insights on HIV cure from antiretroviral treatment interruptions”
Awardees in 2018
Kira Gritsman, M.D., Ph.D.
Albert Einstein College of Medicine
(42nd recipient at 218th ICC Meeting, New York 11-2-18) “PIKing on Leukemia: PI3 Kinase in Normal and Malignant Hematopoiesis”
Samir Parikh, M.D.
Beth Israel Deaconess Medical Center
(41st recipient at 217th ICC Meeting, Boston 4-6-18) “Stress resistance in the kidney: evidence of a PGC1a-NAD+ axis”
Awardees in 2017
Hyung Chun, M.D., F.A.H.A.
Yale University
(40th recipient at 216th ICC Meeting, New Haven 11-3-17) “Endothelial Dysfunction in Health and Disease”
Dung Le, M.D., Ph.D.
Johns Hopkins University
(39th recipient at 215th ICC Meeting, Baltimore 4-7-17) “The Story of Developing Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy”